The description of discrepancy between the principal parameters used to define acromegaly activity (namely, GH and IGF-1) is not a rare phenomenon; it represents a challenge since it can cause misunderstanding for the clinician leading to a complicated management and anxiety for the patient, and finally, it confuses the complex scenario of this systemic disease (21). This evidence concerns the gene GH1 and acromegaly.